Alliance hits double-digit growth
Alliance Pharma, the Aim-listed firm that licenses and markets pharmaceuticals, revealed double-digit profit growth yesterday and issued an upbeat outlook on future earnings. Pre-tax profits climbed 11 per cent to £12m last year, on revenues of £45.5m (up from £44.9m). “We plan to gain momentum from further acquisitions during 2014,” said chairman Michael Gatenby. Shares in the UK-based company closed up 2.6 per cent yesterday.